CXCL8 and COVID-19: We believe that a significant role in driving lung inflammation in COVID-19 patients has to be ascribed also to IL8, that showed higher BAL values among ICU compared to IMW patients (Fig. 3a) and was associated to a negative outcome (Fig. 3c).